Bilateral corneal ulcer in an old man with pemphigus vulgaris

Authors

  • Tania Yelina Silva Chil Hospital General Docente Dr. Juan Bruno Zayas Alfonso, Universidad de Ciencias Médicas. Santiago de Cuba
  • Danay Duperet Carvajal Hospital General Docente Dr. Juan Bruno Zayas Alfonso, Universidad de Ciencias Médicas. Santiago de Cuba https://orcid.org/0000-0002-4015-2549
  • Guadalupe Rinconcillo Medellín Hospital General Docente Dr. Juan Bruno Zayas Alfonso, Universidad de Ciencias Médicas. Santiago de Cuba

Keywords:

corneal ulcer, pemphigus vulgaris, corneal perforation, antibiotic eyewash, immunosupressors agents.

Abstract

The case report of a 72 years patient is described, with diagnosis of pemphigus vulgaris who went to the Ophthalmology Service of Dr. Juan Bruno Zayas Alfonso Teaching General Hospital in Santiago de Cuba because he suffered from ocular redness, together with a decrease vision and abundant secretions of approximately 5 days of history. In the ophthalmological examination the presence of bilateral corneal ulcer was confirmed due to infectious perforation. Treatment was indicated with antibiotic eyewashes (ceftazidime and amikacine), non esteroidal anti-inflammatory drugs, antihypertensive agents and contact lens, with which the injuries of both eyes improved. The infectious process could be due to certain susceptibility to the steroids and systemic inmunosupressors, as therapy associated with pemphigus vulgaris, or to the autoinmune mechanism characterizing this dermatopathy.

Downloads

Download data is not yet available.

References

1. Pinilla García XA. Estudio de las características clínicas y epidemiológicas de los pacientes con enfermedades ampollosas autoinmunes en un hospital de tercer nivel de Bogotá [tesis]. Bogotá: Universidad Nacional de Colombia; 2016 [citado 15/03/2018]. Disponible en: http://bdigital.unal.edu.co/55707/1/1019013841.2017.pdf

2. Peña Pérez ML, Saucedo Rodríguez LR, Jauregui Franco R, Zepeda Rea M, Aguilera Partida J. Pénfigo ocular. Diagnóstico histopatológico. Rev Méd. 2017 [citado 15/03/2018];9(1):85-8. Disponible en: https://www.medigraphic.com/pdfs/revmed/md-2017/md171q.pdf

3. Hrabovska Z, Jautova J, Hrabovsky V. A study of Clinical, histopathological and direct Immunofluorescence diagnosis in pemphigus group Utility of direct immunofluorescence; Bratisl Med J. 2017 [citado 15/03/2018];118(4):243-9. Disponible en: http://www.elis.sk/download_file.php?product_id=5191&session_id=h30mop2appvfpn46i7l7n8ud24

4. Álvarez Guzmán C, Alonso González González L, Rodríguez García A. Queratolisis en pénfigo vulgar. Presentación de un caso. Rev Mex Oftalmol. 2010 [citado 15/03/2018];84(1):61-4. Disponible en: http://www.medigraphic.com/pdfs/revmexoft/rmo-2010/rmo101k.pdf

5. José-Gutiérrez Y, Borque-Ibañez A, Baquedano-Mainar L, Del Agua-Arias C, v Ruiz-Conde MA. Pénfigo vulgar: dificultad en el diagnóstico de un tipo de dermatosis vulvar poco frecuente. Reporte de un caso. Ginecol Obstet Mex. 2017 [citado 18/11/2018];85(8). Disponible en: http://www.medigraphic.com/pdfs/ginobsmex/gom-2017/gom178i.pdf

6. Maderal AD, Miner A, Nousari C, Alonso-llamazares J. Localized pemphigus foliaceus with unilateral. facial in volvemet. Actas Dermosifiliogr. 2014;105(4):413-7.

7. Matos Cruz R, Bascones Martínez A. Pénfigo: Una revisión de la literatura. Av Odontoestomatol. 2009 [citado 18/05/2018];25(2). Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-12852009000200003

Downloads

Published

2019-06-11

How to Cite

1.
Silva Chil TY, Duperet Carvajal D, Rinconcillo Medellín G. Bilateral corneal ulcer in an old man with pemphigus vulgaris. MEDISAN [Internet]. 2019 Jun. 11 [cited 2025 Jun. 1];23(3):526-33. Available from: https://medisan.sld.cu/index.php/san/article/view/2316

Issue

Vol. 23 No. 3 (2019): mayo-junio

Section

Case Reports

License

All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.